NCT01441232View on ClinicalTrials.gov

A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 Diabetics

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

LX4211

400 mg of LX4211 administered as two 200 mg tablets

DRUG

Januvia®

100 mg Januvia® (sitagliptin) administered as one 100 mg sitagliptin tablet

Trial Locations (1)

78209

Lexicon Investigational Site, San Antonio

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY